Efficacy and safety of Interferon-alpha (PDferon B®) and Ribavirin Combination Therapy in patients with Chronic Hepatitis C in Iran

Author(s):
Seyed Moayed AlavianSeyed Moayed Alavian1,*, Masoud Ahmadzad AslMasoud Ahmadzad Asl2, maryam keshvarimaryam keshvari3, Bita BehnavaBita Behnava4, bashir hajibeigibashir hajibeigi5
1Department of Gastroenterology, Baqiyatallah University of Medical Sciences , Dean of Tehran Hepatitis Center, Tehran, Tehran, IR.Iran
2Methodology and Statistics Consultant, Nikan Health Researchers Institute, Tehran Hepatitis Center, Tehran, Tehran, IR.Iran
3Infectious Specialist, Blood Transfusion Research Center, Iran Blood Transfusion Organization, Tehran, Tehran, IR.Iran
4Infectious Specialist, Tehran Hepatitis Center, Tehran, Tehran, IR.Iran
5Blood Transfusion Research Center, Iran Blood Transfusion Organization, Tehran, Tehran, IR.Iran

Hepatitis Monthly:Vol. 6, issue 1; e92946
Published online:Mar 31, 2006
Article type:Research Article
Received:May 05, 2019
Accepted:Mar 31, 2006
How to Cite:Alavian SM, Ahmadzad Asl M, keshvari M, Behnava B, hajibeigi B. Efficacy and safety of Interferon-alpha (PDferon B®) and Ribavirin Combination Therapy in patients with Chronic Hepatitis C in Iran. Hepat Mon. 2006;6(1):e92946. doi:

References

  • 1.
    The references are available in the PDF file.
Share on
Cited by
Metrics

Ordering Reprints

Articles are published under the Creative Commons license stated on each article. No permission or royalty fee is required for uses permitted by that license. CCC handles optional bulk and customized reprint orders. Any quotation covers production and delivery services only, not copyright permission. > Request Reprints from CCC 

Search Relations

Author(s):

Related Articles